113
Views
20
CrossRef citations to date
0
Altmetric
Review

Endothelin receptor antagonism in pulmonary arterial hypertension – a role for selective ETA inhibition?

, &
Pages 2567-2574 | Accepted 17 Oct 2006, Published online: 24 Nov 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Brian Casserly & James R Klinger. (2008) Ambrisentan for the treatment of pulmonary arterial hypertension. Drug Design, Development and Therapy 2, pages 265-280.
Read now
Glaucia Callera, Rita Tostes, Carmine Savoia, M N Muscara & Rhian M Touyz. (2007) Vasoactive peptides in cardiovascular (patho)physiology. Expert Review of Cardiovascular Therapy 5:3, pages 531-552.
Read now

Articles from other publishers (18)

Helen Christou & Raouf A. Khalil. (2022) Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies. American Journal of Physiology-Heart and Circulatory Physiology 322:5, pages H702-H724.
Crossref
Kiran More, Gayatri K Athalye-Jape, Shripada C Rao & Sanjay K Patole. (2016) Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants. Cochrane Database of Systematic Reviews 2016:8.
Crossref
Hena Khanam & Shamsuzzaman. (2015) Bioactive Benzofuran derivatives: A review. European Journal of Medicinal Chemistry 97, pages 483-504.
Crossref
Jin Cai, Ligang Liu, Kwon Ho Hong, Peng Wang, Lushen Li, Meng Cao, Chunlong Sun, Xiaoqing Wu, Xi Zong, Junqing Chen & Min Ji. (2015) Discovery of phenoxybutanoic acid derivatives as potent endothelin antagonists with antihypertensive activity. Bioorganic & Medicinal Chemistry 23:4, pages 657-667.
Crossref
Jin Cai, Junqing Chen, Meng Cao, Peng Wang, Chengliang Feng & Min Ji. (2013) Design, synthesis, and biological evaluation of benzofuran derivatives as ET receptor antagonists. Medicinal Chemistry Research 22:11, pages 5472-5480.
Crossref
Christian W. Kreipke, Anthony Kropinski, Justin Graves, David Tiesma, Michael Kaufman, Steven Schafer, William M. Armstead, Paula Dore-Duffy & Donald M. Kuhn. 2013. Cerebral Blood Flow, Metabolism, and Head Trauma. Cerebral Blood Flow, Metabolism, and Head Trauma 155 163 .
Grzegorz Kopeć, Anna Tyrka, Tomasz Miszalski-Jamka, Tomasz Mikołajczyk, Marcin Waligóra, Tomasz Guzik & Piotr Podolec. (2012) Changes in Exercise Capacity and Cardiac Performance in a Series of Patients with Eisenmenger's Syndrome Transitioned from Selective to Dual Endothelin Receptor Antagonist. Heart, Lung and Circulation 21:11, pages 671-678.
Crossref
M. Patricia George, Hunter C. Champion & Joseph M. Pilewski. (2011) Lung Transplantation for Pulmonary Hypertension. Pulmonary Circulation 1:2, pages 182-191.
Crossref
M. Patricia GeorgeAlexandra BrowerHeather KlingTim ShipleyJan KristoffTodd A. ReinhartMichael Murphey-CorbMark T. GladwinHunter C. ChampionAlison MorrisKaren A. Norris. (2011) Pulmonary Vascular Lesions Are Common in SIV- and SHIV- env -Infected Macaques . AIDS Research and Human Retroviruses 27:2, pages 103-111.
Crossref
Juan C. Roig, James Fink & David J. Burchfield. 2011. Assisted Ventilation of the Neonate. Assisted Ventilation of the Neonate 347 370 .
Rajeev Malhotra & Kenneth D. Bloch. 2011. Textbook of Pulmonary Vascular Disease. Textbook of Pulmonary Vascular Disease 695 711 .
Shahzad G. Raja. (2010) REVIEW: Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: An Overview. Cardiovascular Therapeutics 28:5.
Crossref
Christian W. Kreipke & Jose A. Rafols. (2009) Calponin control of cerebrovascular reactivity: therapeutic implications in brain trauma. Journal of Cellular and Molecular Medicine 13:2, pages 262-269.
Crossref
Xin Li, Ke-Liang Liu, Jian-Quan Zheng, Mu-Gen Chi, Jun-Jun Dong, Si-Jian Dong & Ze-Hui Gong. (2008) Pharmacological characterization of 3-azabicyclo[3,2,1] octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel ETA receptor-selective antagonist. Pulmonary Pharmacology & Therapeutics 21:5, pages 780-787.
Crossref
I. Marie, S. Bekri & H. Lévesque. (2008) Endothéline 1 et sélectivité des antagonistes des récepteurs de l’endothéline 1 : to B or not to B ?. La Revue de Médecine Interne 29:4, pages 263-268.
Crossref
Dennis J. CadaTerri LevienDanial E. Baker. (2017) Ambrisentan. Hospital Pharmacy 42:12, pages 1145-1154.
Crossref
Misuk Kang, Ka Young Chung & Jeffery W. Walker. (2007) G-Protein Coupled Receptor Signaling in Myocardium: Not for the Faint of Heart. Physiology 22:3, pages 174-184.
Crossref
Woo Seok LeeKye Hun KimDae Ho JeongKi Hong LeeSeo Na HongHyung Wook ParkJu Han KimYoung Keun AhnMyung Ho JeongJeong Gwan ChoJong Chun Park. (2007) Clinical Characteristics and Prognostic Factors of Patients with Severe Pulmonary Hypertension. Korean Circulation Journal 37:6, pages 265.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.